维普中文期刊产品整合服务
35篇 您的检索式:作者名="Goekbuget N"
    题名 作者 年代 出处 被引量
1Prognostic implications of mutations and expression of the Wilms tumor I (WT I) gene in adult acute T- lymphoblastic leukemia 显示文摘Heesch S Goekbuget N Stroux A 2010Haematologica2010,95,6:1
2Results of a shortened,dose reduced treatment protocol in elderly patients with aute lymphoblastic leukemia (ALL)显示文摘Goekbuget N de Wit M Gerhardt A 2000Blood2000,96,1:1
3Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) 显示文摘Wassmann B Pfeifer H Goekbuget N 2006Blood2006,108,5:1
4Alternating versus concurrent schedules of Imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) 显示文摘Wassmann B Pfeifer H Goekbuget N 2006Blood2006,108,5:1
5Clinical activity of the anti-CD19 bite (R) blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL):Interim results of a phase II study显示文摘Topp M S Goekbuget N Zugmaier G 0,,:1
6Alternating versus concurrent schedules of imatinib and chemotherepy as front-line therapy for philadelphia-positive acute lymphoblastic leukemia(ph《'+》 ALL)显示文摘 Pfeifer H Goekbuget N 2006Blood2006,108,11:1
7Alternating versus concurrent schedules of imatinib and chemotherapy as front - line therapy for Philadelphia - positive acute lymphoblastic leukemia ( Ph + ALL) 显示文摘Wassmann B Pfeifer H Goekbuget N 2006Blood2006,108,5:1
8Subtype adjusted therapy improves outcome of elderly patients with acute lymphoblastic leukemia (ALL) E abstract 显示文摘HOELZER D GOEKBUGET N BECK J 2004Blood2004,104,:1
9Alternating versus con-current schedules of imatinib and chemotherapy as front-line therapy forPhiladelphia-positive acute lymphoblastic leukemia ( Ph + ALL) 显示文摘Wassmann B Pfeifer H Goekbuget N 2006Blood2006,108,5:1
10Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) 显示文摘WASSMANN B PFEIFER H GOEKBUGET N 2006Blood2006,108,:1
11Clinical activity of the anti CD19 BITE blinatumomab in patients with relapsed/refractory B-precursor acute lym phoblastic leukemia: interim results of a phase 2 study 显示文摘TOPP M GOEKBUGET N ZUGMAIER G 2011Haematologiea2011,,:1
12Prognostic implications of NOTCH1and FBXW7mutations in adult acute T-lymphoblastic leukemia显示文摘Baldus CD Thibaut J Goekbuget N 2009Haematologica2009,94,:1
13High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia 显示文摘Kuhnl A Goekbuget N Stroux A 2010Blood2010,115,18:1
14Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)显示文摘Wassmann B Pfeifer H Goekbuget N et a1 2006Blood2006,108,5:1
15Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lym- phoblastic leukemia(Ph^+ ALL)显示文摘Wassmann B Pfeifer H Goekbuget N 2006Blood2006,108,5:1
16Alternating versus concurrent schedules of imatinib and chemotherapy as front-hne therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) 显示文摘Wassrsann B Pfeifer H Goekbuget N 2006Blood2006,108,5:1
17Treatment with anti-CD19 BiTE antibody blinatumomab(MT103/MEDI-538)is able to eliminate minimal residual disease(MRD) in patients with B-precursor acute lymphoblastic leukemia(ALL):first reuslts of an ongoing phase II study显示文摘Topp M Goekbuget N Kufer P 2008Blood2008,112,:1
18Alternating versus concurrent schedules of imatinib and chemothera- py as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph ALL) 显示文摘Wassmann B Pfeifer H Goekbuget N 2006Blood2006,108,5:1
19Effect of anti- CD19 BiTE blinatumomab on complete remission rate and overall survival in adult patients with relapsed/refractory B- precursor ALL 显示文摘Topp M Goekbuget N Zugmaier G 2012J Clin Oncol2012,30,15:1
20Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia 显示文摘Baldus CD Thibaut J Goekbuget N 2009Haematologica2009,94,10:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费